Indeks akhir pekan yang lalu berhasil capai all-time high. Batas koreksi kritis di 7650-7560. Sedangkan dari pola inverted head and shoulders sejak Mar24 maka target teoritis jangka menengah di sekitar 7920.
Untuk hari ini Analis Teknikal menyukai saham-saham BBRI, BBNI, AMMN, ASRI, BFIN, dan ERAA dengan rating trading buy.
Day Trading Picks
Top Picks Today (Technical):
BBRI (5225); BUY-TP @5325-5400; Cutloss <5125
BBNI (5650); BUY-TP @5800-5925; Cutloss <5525
AMMN (10900); BUY-TP @11300-11800; Cutloss <10500
ASRI (242); BUY-TP @270-286; Cutloss <230
BFIN (1000); BUY-TP @1035-1060; Cutloss <955
ERAA (442); BUY-TP @456-464; Cutloss <430
<DISC. ON>
Laporan selengkapnya dapat di-click di sini
Samuel Sekuritas Indonesia is a leading Indonesian securities brokerage firm. Established in 1997, the firm has grown to become one of the most respected and trusted financial services companies in the country. With a wide range of services and products, Samuel Sekuritas Indonesia has become a trusted partner to many investors, both institutional and individual.
The company offers a variety of financial services, including equity, debt and derivative securities brokerage services, research and portfolio management, asset management and capital market services, as well as a range of other investment solutions. Samuel Sekuritas Indonesia is also a leader in providing financial education and training, and has established itself as a leading provider of investor relations services.
The company has a strong research capability and is committed to providing its clients with up-to-date and reliable market analysis and recommendations. It also has a team of experienced and knowledgeable professionals who are dedicated to providing quality service to its clients. As a result, Samuel Sekuritas Indonesia has become a preferred partner for many investors in Indonesia.
In addition to its financial services, Samuel Sekuritas Indonesia also offers a range of other services, such as corporate finance and advisory services, mergers and acquisitions, and venture capital.